Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radionuclide Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Beta-emitting
1.2.3 Targeted Alpha Therapy
1.3 Market by Application
1.3.1 Global Targeted Radionuclide Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Solid Tumor
1.3.3 Non Hodgkin Lymphoma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radionuclide Therapy Market Perspective (2018-2029)
2.2 Targeted Radionuclide Therapy Growth Trends by Region
2.2.1 Global Targeted Radionuclide Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Radionuclide Therapy Historic Market Size by Region (2018-2024)
2.2.3 Targeted Radionuclide Therapy Forecasted Market Size by Region (2024-2029)
2.3 Targeted Radionuclide Therapy Market Dynamics
2.3.1 Targeted Radionuclide Therapy Industry Trends
2.3.2 Targeted Radionuclide Therapy Market Drivers
2.3.3 Targeted Radionuclide Therapy Market Challenges
2.3.4 Targeted Radionuclide Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Radionuclide Therapy Players by Revenue
3.1.1 Global Top Targeted Radionuclide Therapy Players by Revenue (2018-2024)
3.1.2 Global Targeted Radionuclide Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Targeted Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Radionuclide Therapy Revenue
3.4 Global Targeted Radionuclide Therapy Market Concentration Ratio
3.4.1 Global Targeted Radionuclide Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Therapy Revenue in 2022
3.5 Targeted Radionuclide Therapy Key Players Head office and Area Served
3.6 Key Players Targeted Radionuclide Therapy Product Solution and Service
3.7 Date of Enter into Targeted Radionuclide Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radionuclide Therapy Breakdown Data by Type
4.1 Global Targeted Radionuclide Therapy Historic Market Size by Type (2018-2024)
4.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2024-2029)
5 Targeted Radionuclide Therapy Breakdown Data by Application
5.1 Global Targeted Radionuclide Therapy Historic Market Size by Application (2018-2024)
5.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Radionuclide Therapy Market Size (2018-2029)
6.2 North America Targeted Radionuclide Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeted Radionuclide Therapy Market Size by Country (2018-2024)
6.4 North America Targeted Radionuclide Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Radionuclide Therapy Market Size (2018-2029)
7.2 Europe Targeted Radionuclide Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeted Radionuclide Therapy Market Size by Country (2018-2024)
7.4 Europe Targeted Radionuclide Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radionuclide Therapy Market Size (2018-2029)
8.2 Asia-Pacific Targeted Radionuclide Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Radionuclide Therapy Market Size (2018-2029)
9.2 Latin America Targeted Radionuclide Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeted Radionuclide Therapy Market Size by Country (2018-2024)
9.4 Latin America Targeted Radionuclide Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radionuclide Therapy Market Size (2018-2029)
10.2 Middle East & Africa Targeted Radionuclide Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Radionuclide Therapy Introduction
11.1.4 Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Targeted Radionuclide Therapy Introduction
11.2.4 Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Lantheus
11.3.1 Lantheus Company Detail
11.3.2 Lantheus Business Overview
11.3.3 Lantheus Targeted Radionuclide Therapy Introduction
11.3.4 Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.3.5 Lantheus Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Detail
11.4.2 Aurobindo Pharma Business Overview
11.4.3 Aurobindo Pharma Targeted Radionuclide Therapy Introduction
11.4.4 Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.4.5 Aurobindo Pharma Recent Development
11.5 Mundipharma
11.5.1 Mundipharma Company Detail
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Targeted Radionuclide Therapy Introduction
11.5.4 Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.5.5 Mundipharma Recent Development
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Detail
11.6.2 China Isotope & Radiation Business Overview
11.6.3 China Isotope & Radiation Targeted Radionuclide Therapy Introduction
11.6.4 China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.6.5 China Isotope & Radiation Recent Development
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Detail
11.7.2 Curium Pharmaceuticals Business Overview
11.7.3 Curium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.7.4 Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.7.5 Curium Pharmaceuticals Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Targeted Radionuclide Therapy Introduction
11.8.4 Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Detail
11.9.2 Clarity Pharmaceuticals Business Overview
11.9.3 Clarity Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.9.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.9.5 Clarity Pharmaceuticals Recent Development
11.10 Curasight
11.10.1 Curasight Company Detail
11.10.2 Curasight Business Overview
11.10.3 Curasight Targeted Radionuclide Therapy Introduction
11.10.4 Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.10.5 Curasight Recent Development
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Detail
11.11.2 Nordic Nanovector Business Overview
11.11.3 Nordic Nanovector Targeted Radionuclide Therapy Introduction
11.11.4 Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.11.5 Nordic Nanovector Recent Development
11.12 Philogen
11.12.1 Philogen Company Detail
11.12.2 Philogen Business Overview
11.12.3 Philogen Targeted Radionuclide Therapy Introduction
11.12.4 Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.12.5 Philogen Recent Development
11.13 RadioMedix
11.13.1 RadioMedix Company Detail
11.13.2 RadioMedix Business Overview
11.13.3 RadioMedix Targeted Radionuclide Therapy Introduction
11.13.4 RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.13.5 RadioMedix Recent Development
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Detail
11.14.2 Telix Pharmaceuticals Business Overview
11.14.3 Telix Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.14.4 Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.14.5 Telix Pharmaceuticals Recent Development
11.15 Orano Med
11.15.1 Orano Med Company Detail
11.15.2 Orano Med Business Overview
11.15.3 Orano Med Targeted Radionuclide Therapy Introduction
11.15.4 Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.15.5 Orano Med Recent Development
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Detail
11.16.2 Actinium Pharmaceuticals Business Overview
11.16.3 Actinium Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.16.4 Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.16.5 Actinium Pharmaceuticals Recent Development
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Detail
11.17.2 Y-mAbs Therapeutics Business Overview
11.17.3 Y-mAbs Therapeutics Targeted Radionuclide Therapy Introduction
11.17.4 Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.17.5 Y-mAbs Therapeutics Recent Development
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Detail
11.18.2 Fusion Pharmaceuticals Business Overview
11.18.3 Fusion Pharmaceuticals Targeted Radionuclide Therapy Introduction
11.18.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
11.18.5 Fusion Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Radionuclide Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Beta-emitting
Table 3. Key Players of Targeted Alpha Therapy
Table 4. Global Targeted Radionuclide Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Targeted Radionuclide Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Targeted Radionuclide Therapy Market Share by Region (2018-2024)
Table 8. Global Targeted Radionuclide Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Targeted Radionuclide Therapy Market Share by Region (2024-2029)
Table 10. Targeted Radionuclide Therapy Market Trends
Table 11. Targeted Radionuclide Therapy Market Drivers
Table 12. Targeted Radionuclide Therapy Market Challenges
Table 13. Targeted Radionuclide Therapy Market Restraints
Table 14. Global Targeted Radionuclide Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Targeted Radionuclide Therapy Market Share by Players (2018-2024)
Table 16. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2022)
Table 17. Ranking of Global Top Targeted Radionuclide Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Targeted Radionuclide Therapy Product Solution and Service
Table 21. Date of Enter into Targeted Radionuclide Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2018-2024)
Table 29. Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Targeted Radionuclide Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Targeted Radionuclide Therapy Product
Table 49. Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Targeted Radionuclide Therapy Product
Table 54. Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Lantheus Company Detail
Table 57. Lantheus Business Overview
Table 58. Lantheus Targeted Radionuclide Therapy Product
Table 59. Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 60. Lantheus Recent Development
Table 61. Aurobindo Pharma Company Detail
Table 62. Aurobindo Pharma Business Overview
Table 63. Aurobindo Pharma Targeted Radionuclide Therapy Product
Table 64. Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 65. Aurobindo Pharma Recent Development
Table 66. Mundipharma Company Detail
Table 67. Mundipharma Business Overview
Table 68. Mundipharma Targeted Radionuclide Therapy Product
Table 69. Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 70. Mundipharma Recent Development
Table 71. China Isotope & Radiation Company Detail
Table 72. China Isotope & Radiation Business Overview
Table 73. China Isotope & Radiation Targeted Radionuclide Therapy Product
Table 74. China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 75. China Isotope & Radiation Recent Development
Table 76. Curium Pharmaceuticals Company Detail
Table 77. Curium Pharmaceuticals Business Overview
Table 78. Curium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 79. Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 80. Curium Pharmaceuticals Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Targeted Radionuclide Therapy Product
Table 84. Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Clarity Pharmaceuticals Company Detail
Table 87. Clarity Pharmaceuticals Business Overview
Table 88. Clarity Pharmaceuticals Targeted Radionuclide Therapy Product
Table 89. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 90. Clarity Pharmaceuticals Recent Development
Table 91. Curasight Company Detail
Table 92. Curasight Business Overview
Table 93. Curasight Targeted Radionuclide Therapy Product
Table 94. Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 95. Curasight Recent Development
Table 96. Nordic Nanovector Company Detail
Table 97. Nordic Nanovector Business Overview
Table 98. Nordic Nanovector Targeted Radionuclide Therapy Product
Table 99. Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 100. Nordic Nanovector Recent Development
Table 101. Philogen Company Detail
Table 102. Philogen Business Overview
Table 103. Philogen Targeted Radionuclide Therapy Product
Table 104. Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 105. Philogen Recent Development
Table 106. RadioMedix Company Detail
Table 107. RadioMedix Business Overview
Table 108. RadioMedix Targeted Radionuclide Therapy Product
Table 109. RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 110. RadioMedix Recent Development
Table 111. Telix Pharmaceuticals Company Detail
Table 112. Telix Pharmaceuticals Business Overview
Table 113. Telix Pharmaceuticals Targeted Radionuclide Therapy Product
Table 114. Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 115. Telix Pharmaceuticals Recent Development
Table 116. Orano Med Company Detail
Table 117. Orano Med Business Overview
Table 118. Orano Med Targeted Radionuclide Therapy Product
Table 119. Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 120. Orano Med Recent Development
Table 121. Actinium Pharmaceuticals Company Detail
Table 122. Actinium Pharmaceuticals Business Overview
Table 123. Actinium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 124. Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 125. Actinium Pharmaceuticals Recent Development
Table 126. Y-mAbs Therapeutics Company Detail
Table 127. Y-mAbs Therapeutics Business Overview
Table 128. Y-mAbs Therapeutics Targeted Radionuclide Therapy Product
Table 129. Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 130. Y-mAbs Therapeutics Recent Development
Table 131. Fusion Pharmaceuticals Company Detail
Table 132. Fusion Pharmaceuticals Business Overview
Table 133. Fusion Pharmaceuticals Targeted Radionuclide Therapy Product
Table 134. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 135. Fusion Pharmaceuticals Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Radionuclide Therapy Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Targeted Radionuclide Therapy Market Share by Type: 2022 VS 2029
Figure 3. Beta-emitting Features
Figure 4. Targeted Alpha Therapy Features
Figure 5. Global Targeted Radionuclide Therapy Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Targeted Radionuclide Therapy Market Share by Application: 2022 VS 2029
Figure 7. Solid Tumor Case Studies
Figure 8. Non Hodgkin Lymphoma Case Studies
Figure 9. Targeted Radionuclide Therapy Report Years Considered
Figure 10. Global Targeted Radionuclide Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Targeted Radionuclide Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Targeted Radionuclide Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global Targeted Radionuclide Therapy Market Share by Players in 2022
Figure 14. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Targeted Radionuclide Therapy Revenue in 2022
Figure 16. North America Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 18. United States Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 22. Germany Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Targeted Radionuclide Therapy Market Share by Region (2018-2029)
Figure 30. China Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 38. Mexico Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Targeted Radionuclide Therapy Market Share by Country (2018-2029)
Figure 42. Turkey Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Targeted Radionuclide Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 45. Novartis Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 46. Lantheus Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 47. Aurobindo Pharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 48. Mundipharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 49. China Isotope & Radiation Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 50. Curium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 51. Gilead Sciences Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 52. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 53. Curasight Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 54. Nordic Nanovector Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 55. Philogen Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 56. RadioMedix Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 57. Telix Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 58. Orano Med Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 59. Actinium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 60. Y-mAbs Therapeutics Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 61. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed